Christine Icard-Liepkalns

Title: Christine Icard-Liepkalns: Innovator in Basic Helix-Loop-Helix Polypeptides

Introduction

Christine Icard-Liepkalns is a notable inventor based in Tampa, FL (US). She has made significant contributions to the field of molecular biology, particularly in the area of basic helix-loop-helix (bHLH) polypeptides. Her work has implications for understanding and treating various nervous system disorders.

Latest Patents

Christine holds a patent for "Polypeptides of the 'basic helix-loop-helix' bHLH family, corresponding nucleic acid sequences." This invention relates to nucleic acids that encode novel basic helix-loop-helix polypeptides, including rat Relax and human ngn3 polypeptides. The patent also covers methods for detecting these nucleic acids and polypeptides, as well as activators or inhibitors of the polypeptides. Furthermore, it addresses methods for the prevention and treatment of pathologies affecting the nervous system.

Career Highlights

Christine is associated with Centelion Sas, where she applies her expertise in molecular biology. Her innovative work has led to advancements in understanding the role of bHLH polypeptides in various biological processes.

Collaborations

Christine has collaborated with notable colleagues such as Jacques Mallet and Philippe Ravassard. These partnerships have enhanced her research and contributed to the development of her patented technologies.

Conclusion

Christine Icard-Liepkalns is a pioneering inventor whose work on basic helix-loop-helix polypeptides has the potential to impact the treatment of nervous system disorders. Her contributions to molecular biology continue to inspire advancements in the field.